|
Volumn 342, Issue 6165, 2013, Pages 1453-1454
|
A common pathway for a rare disease?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE TRIPHOSPHATE;
IRON SULFUR PROTEIN;
LACTIC ACID;
MAMMALIAN TARGET OF RAPAMYCIN;
MITOCHONDRIAL DNA;
PYRUVIC ACID;
RAPAMYCIN;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;
MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1;
MTOR PROTEIN, MOUSE;
MULTIPROTEIN COMPLEX;
NEUROPROTECTIVE AGENT;
TARGET OF RAPAMYCIN KINASE;
CHILD HEALTH;
DISEASE INCIDENCE;
DRUG;
MITOCHONDRION;
NUMERICAL MODEL;
AGING;
ALZHEIMER DISEASE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
BASAL GANGLION;
BRAIN DAMAGE;
BRAIN MITOCHONDRION;
BRAIN STEM;
CHILD;
CHILDHOOD MORTALITY;
DEGENERATIVE DISEASE;
DISEASE COURSE;
ENZYME DEFICIENCY;
HUMAN;
INFANT;
LEIGH DISEASE;
LIFESPAN;
MOUSE;
NEUROIMAGING;
NEUROLOGIC DISEASE;
NEUROPATHOLOGY;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
ONSET AGE;
OXIDATIVE PHOSPHORYLATION;
PARKINSON DISEASE;
PRIORITY JOURNAL;
PUTAMEN;
RARE DISEASE;
SHORT SURVEY;
SYMPTOM;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
MITOCHONDRIAL DISEASES;
MOLECULARLY TARGETED THERAPY;
DISORDERS OF MITOCHONDRIAL FUNCTIONS;
DRUG ANTAGONISM;
NOTE;
ANIMALS;
LEIGH DISEASE;
MITOCHONDRIAL DISEASES;
MOLECULAR TARGETED THERAPY;
MULTIPROTEIN COMPLEXES;
NEUROPROTECTIVE AGENTS;
SIROLIMUS;
TOR SERINE-THREONINE KINASES;
|
EID: 84890809938
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1248449 Document Type: Short Survey |
Times cited : (22)
|
References (11)
|